Showing 1 - 19 results of 19 for search 'Jonathan S Wall', query time: 0.05s
Refine Results
-
1
-
2
-
3
Dual-Energy SPECT and the Development of Peptide p5+14 for Imaging Amyloidosis by Jonathan S. Wall PhD, Stephen J. Kennel PhD, Emily B. Martin PhD
Published 2017-08-01
Article -
4
-
5
-
6
-
7
-
8
Assessing ad-hoc adaptations’ alignment with therapeutic goals: a qualitative study of lay counselor-delivered family therapy in Eldoret, Kenya by Bonnie N. Kaiser, Julia Kaufman, Jonathan Taylor Wall, Elsa A. Friis Healy, David Ayuku, Gregory A. Aarons, Eve S. Puffer
Published 2023-08-01
Article -
9
-
10
-
11
AL amyloid imaging and therapy with a monoclonal antibody to a cryptic epitope on amyloid fibrils. by Jonathan S Wall, Stephen J Kennel, Angela Williams, Tina Richey, Alan Stuckey, Ying Huang, Sallie Macy, Robert Donnell, Robin Barbour, Peter Seubert, Dale Schenk
Published 2012-01-01
Article -
12
Clinical Confirmation of Pan-Amyloid Reactivity of Radioiodinated Peptide <sup>124</sup>I-p5+14 (AT-01) in Patients with Diverse Types of Systemic Amyloidosis Demonstrated by PET/C... by Emily B. Martin, Alan Stuckey, Dustin Powell, Ronald Lands, Bryan Whittle, Craig Wooliver, Sallie Macy, James S. Foster, Spencer Guthrie, Stephen J. Kennel, Jonathan S. Wall
Published 2023-04-01
Article -
13
Anticytomegalovirus Peptides Point to New Insights for CMV Entry Mechanisms and the Limitations of <italic toggle="yes">In Vitro</italic> Screenings by Joseph W. Jackson, Trevor J. Hancock, Pranay Dogra, Ravi Patel, Ravit Arav-Boger, Angela D. Williams, Stephen J. Kennel, Jonathan S. Wall, Tim E. Sparer
Published 2019-02-01
Article -
14
A binding-site barrier affects imaging efficiency of high affinity amyloid-reactive peptide radiotracers in vivo. by Jonathan S Wall, Angela Williams, Tina Richey, Alan Stuckey, Ying Huang, Craig Wooliver, Sallie Macy, Eric Heidel, Neil Gupta, Angela Lee, Brianna Rader, Emily B Martin, Stephen J Kennel
Published 2013-01-01
Article -
15
Development and characterization of a prototypic pan-amyloid clearing agent – a novel murine peptide-immunoglobulin fusion by James S. Foster, Manasi Balachandran, Trevor J. Hancock, Emily B. Martin, Sallie Macy, Craig Wooliver, Tina Richey, Alan Stuckey, Angela D. Williams, Joseph W. Jackson, Stephen J. Kennel, Jonathan S. Wall
Published 2023-10-01
Article -
16
Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral Amyloidosis by Jonathan S. Wall, Emily B. Martin, Tina Richey, Alan C. Stuckey, Sallie Macy, Craig Wooliver, Angela Williams, James S. Foster, Penney McWilliams-Koeppen, Ed Uberbacher, Xiaolin Cheng, Stephen J. Kennel
Published 2015-04-01
Article -
17
-
18
Light Chain Amyloid Fibrils Cause Metabolic Dysfunction in Human Cardiomyocytes. by Helen P McWilliams-Koeppen, James S Foster, Nicole Hackenbrack, Marina Ramirez-Alvarado, Dallas Donohoe, Angela Williams, Sallie Macy, Craig Wooliver, Dale Wortham, Jennifer Morrell-Falvey, Carmen M Foster, Stephen J Kennel, Jonathan S Wall
Published 2015-01-01
Article -
19
A harmonized chemical monitoring database for support of exposure assessments by Kristin K. Isaacs, Jonathan T. Wall, Ashley R. Williams, Kevin A. Hobbie, Jon R. Sobus, Elin Ulrich, David Lyons, Kathie L. Dionisio, Antony J. Williams, Christopher Grulke, Caroline A. Foster, Josiah McCoy, Charles Bevington
Published 2022-06-01
Article